Podcasts about Massachusetts General Hospital

Edward Ryan is the director of global infectious diseases at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.T. Ryan, F. Qadri, and J.A. Lynch. Global Cholera-Control Efforts — Progress and Remaining Challenges. N Engl J Med 2026;394:2177-2180.

The job of scientists is a tough one - to take complex, multifaceted, messy concepts, and do their best to simplify them in a way that is understandable and digestible to the general public. However, today's guest, Dr. Lisa Feldman Barrett,  warns that if something is too simple, we probably shouldn't believe it.  Especially when it comes to human behavior and emotions, there's nothing simple about it - because variation is the norm - not averages.  And in today's episode, Dr. Barrett explains exactly why that is and how it should change the way we view and approach our interactions. Dr. Barrett is among the top 1% most cited scientists in the world for her revolutionary research in psychology and neuroscience. She is a University Distinguished Professor of Psychology at Northeastern University, and she holds appointments at Harvard Medical School and Massachusetts General Hospital, where she serves as Chief Science Officer for the Center of Law, Brain and Behavior. In addition to the books 7 ½ Lessons About the Brain and How Emotions Are Made, Dr. Barrett has published over 260 peer reviewed scientific papers. Not only do we dive into the scientific research that disproves the way many of us have been led to view emotions, Dr. Barrett also does a phenomenal job of speaking to these concepts in a way that helps us apply it to our daily lives. Specifically, we address “The Great Man Theory” - why there is no one-size fits all approach to emotions and what they mean How understanding emotional constructs on a deeper level can make people more adept at navigating social situations The physiological and psychological processes of how we give meaning to our emotions Specific instances where knowing this information can directly influence life outcomes for you and those you impact daily Referenced Resources: Website: Lisafeldmanbarrett.com Book: How Emotions Are Made Book:  7 ½ Lessons About the Brain  TED Talk: You Aren't At the Mercy of Your Emotions Research Article: Knowing what you're feeling and knowing what to do about it   Resources & Links: Art of Coaching for coaching programs and resources: https://artofcoaching.com/mentoring My Latest Book (Link to upcoming or referenced publication): https://amzn.to/4rZknhs Connect with Brett Bartholomew: LinkedIn Twitter   Follow Us: Website: ArtofCoaching.com Instagram: @coach_brettb X: @coach_brettb

"Radiation therapy is often extremely well tolerated in colorectal cancer. Technology has really changed things. But location of the tumor can affect side effects, such as radiation dermatitis. If a patient has a low-lying tumor, if it's less than six centimeters from the anal verge, the patient is likely to have some skin reaction. It's good to be proactive if that's the case," ONS member Lorraine Drapek, DNP, FNP-BC, AOCNP®, nurse practitioner in the Department of Radiation Oncology at Massachusetts General Hospital in Boston, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radiation side effects in colorectal cancer. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 5, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the side effects of radiation to treat colorectal cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 374: Colorectal Cancer Treatment Considerations for Nurses Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer High-Fiber Diet Reduces Diarrhea in Colorectal Cancer Survivors Hyperbaric Oxygen Therapy Shows Promise for Certain Radiation Side Effects Increasing Incidence of Colorectal Cancer in Younger Adults Is a Call to Action for Oncology Nurses Oncology Drug Reference Sheet: 5-Fluorouracil Oncology Drug Reference Sheet: Oxaliplatin Oncology Nurses Are Key in Sexual Health Conversations With Minority Women Sexual Considerations for Patients With Cancer The Intersection of Pelvic Health and Oncology Optimizes Sexual Symptom Management ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS/ONCC® Radiation Therapy Certificate™ ONS ROCN™ Certification Review™ Clinical Journal of Oncology Nursing articles: Sexual Dysfunction: Common Side Effect Updated Interventions for Radiation-Induced Diarrhea: Putting Evidence Into Practice With the Oncology Nursing Society Physical Activity: A Systematic Review to Inform Nurse Recommendations During Treatment for Colorectal Cancer ONS Learning Libraries: Colorectal Cancer Radiation Advanced Practitioner Society for Hematology and Oncology American Society for Radiation Oncology American Society of Clinical Oncology Clinical Practice Guidelines Colontown Colorectal Cancer Alliance To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "In recent years, there has been more nonsurgical management of rectal cancer, especially in what we call the low-lying population. This is the population of patients who would likely end up with a permanent colostomy because their cancer is so low in terms of being close to or involving the anal verge. There is now a regimen where these patients can get their chemotherapy followed by their chemoradiation and then be monitored on close surveillance without surgery." TS 2:23 "Another assessment would be to assess what effects have they had from their chemotherapy that they're bringing with them. FOLFOX-based treatment is commonly used, and the platinum therapy oxaliplatin often causes peripheral neuropathy. What is the patient having? What are those symptoms like? Are they having peripheral neuropathy? If they are that is likely not going to get better or improve during their whole course of radiation. In fact, sometimes when oxaliplatin therapy stops, the peripheral neuropathy can get worse as patients are going through other treatments." TS 5:42 "If the patient has a low-lying tumor, if it's less than six centimeters from the anal verge, the patient is likely to have some skin reaction. It's good to be proactive if that's the case. And then proactively minimizing radiation dermatitis effects, such as keeping the area clean, good washing of the area, and prophylactically starting them on or having someone start them on steroid creams a couple of times a day to minimize that radiation dermatitis effect in the long run." TS 7:25 "I have a sexual health clinic for women with these effects. It's very important as nurses that if you can develop the comfort to ask patients about their sexual activity—it's hard, but it really needs to be done. And I will tell you that the healthcare providers are not doing it. They don't have time, and like us as nurses, we don't get this in school, and neither do they. The other providers don't get it in school either, but it's important. Patients are getting more and more worried about their sexual health. They're coming to us at a younger age, and this is really, really important to address." TS 15:35 "I would say that working with your advanced practice providers and education for advanced practice providers has definitely been focusing on [sexual health] more. Your PAs and your NPs—I think they're going to have the ears and the wherewithal to be able to be your allies and colleagues in this. By and large, it's my APP colleagues and nursing that I talk to the most about this. … Again, it's not an easy thing to bring forward, having dilators in place. But I will tell you in the department that I work in, it was me and couple of nurses who pushed this issue with the physicians for two years and finally got it put in place. It can be done. There's a lot more centers out there doing that." TS 21:51

What if the same brain states people spend years chasing through psychedelics could be accessed through meditation alone, and in as little as seven days? In this fascinating solo episode, Darin Olien explores groundbreaking new research from University of California San Diego, Harvard University, Massachusetts General Hospital, and University of Montreal suggesting that meditation may produce brain patterns remarkably similar to those observed during psychedelic experiences. From the suppression of the default mode network and increases in neural complexity to neuroplasticity, endogenous opioids, and measurable biological changes in the bloodstream, Darin unpacks the science behind one of the most powerful, and completely free tools available to human beings. He also walks listeners through a practical seven-day protocol combining focused-attention meditation, Vipassana, breathwork, walking meditation, and loving-kindness practices designed to help cultivate greater awareness, emotional resilience, cognitive flexibility, and inner peace. What You'll Learn The groundbreaking UC San Diego meditation study and its surprising findings Why meditation may create brain states similar to psilocybin What the default mode network is and how it shapes everyday thinking How meditation may reduce rumination, anxiety, and self-referential thought The concept of brain criticality and cognitive flexibility Why post-meditation blood samples stimulated neuronal growth How meditation influences neuroplasticity and whole-body biology The differences between Samatha and Vipassana meditation What advanced monks are teaching scientists about consciousness The limitations and caveats of current meditation research A practical seven-day meditation protocol anyone can begin Why meditation may be one of the most powerful health interventions available today Chapters 00:00:03 – Welcome to SuperLife 00:00:33 – Sponsor: Alkemis and the hidden toxicity of indoor air 00:00:57 – Conventional paints, petrochemicals, and endocrine disruptors 00:01:24 – Why VOCs and PFAS may be affecting your home environment 00:01:55 – Fire-resistant mineral paints and healthier living spaces 00:02:27 – Cradle to Cradle certification and sustainable design 00:03:23 – The meditation study Darin can't stop thinking about 00:03:33 – Scanning the brains and blood of meditators 00:03:44 – Brain activity resembling psilocybin experiences 00:04:09 – The promise of a seven-day meditation protocol 00:04:22 – Psychedelics, consciousness, and dissolving the sense of self 00:04:47 – Ancient practices and modern scientific validation 00:05:23 – Why meditation research is entering a renaissance 00:05:41 – Harvard, Massachusetts General Hospital, and advanced consciousness mapping 00:06:00 – University of Montreal's study of monks with 15,000+ hours of practice 00:06:16 – Why psychedelics and meditation are converging scientifically 00:06:37 – What listeners will learn in today's episode 00:06:54 – Breaking down the UC San Diego retreat study 00:07:18 – Thirty-three hours of meditation, breathwork, and group practice 00:07:42 – EEG scans, blood draws, and laboratory neuron testing 00:08:05 – Reduced activity in the default mode network 00:08:24 – The science of mental chatter and rumination 00:08:50 – Blood plasma stimulating new neuronal growth 00:09:02 – Neuroplasticity and new neural connections 00:09:29 – Increased cellular metabolism and endogenous opioids 00:10:13 – Samatha vs Vipassana meditation explained 00:10:42 – How different meditation styles reshape the brain 00:10:50 – Harvard's advanced meditation consciousness studies 00:11:18 – Mapping concentration states and consciousness cessation 00:11:46 – Ancient contemplative traditions meeting modern neuroscience 00:11:50 – Important limitations of the research 00:12:05 – Why advanced monks aren't average practitioners 00:12:20 – Correlation versus causation in psychedelic comparisons 00:12:48 – What may actually be happening inside the brain 00:13:03 – Understanding the default mode network 00:13:26 – Anxiety, depression, addiction, and overactive self-talk 00:13:53 – Why meditation and psilocybin share common neurological effects 00:14:10 – Beginner studies showing measurable brain changes 00:14:28 – Brain criticality and cognitive adaptability 00:14:48 – The most surprising finding: meditation changes the blood 00:15:05 – Meditation as a whole-body signaling event 00:15:18 – Better sleep, digestion, hormone balance, and recovery 00:15:39 – Neuroplasticity, immune function, metabolism, and pain regulation 00:15:56 – Why meditation may be the ultimate free medicine 00:16:10 – Introducing the seven-day meditation protocol 00:16:34 – Sponsor break: Alkemis Paint 00:19:02 – Building a research-backed at-home meditation practice 00:19:24 – Why consistency matters more than total hours 00:19:41 – Combining focused attention and open monitoring 00:19:53 – Days 1–3: Stabilizing attention 00:20:02 – Morning focused-attention meditation instructions 00:20:34 – Evening body scan practice 00:21:04 – Preparing the brain for deeper awareness 00:21:08 – Days 4–5: Opening awareness through Vipassana 00:21:31 – Letting thoughts, sensations, and sounds pass freely 00:21:39 – Evening box breathing for nervous system regulation 00:22:01 – Why days four and five often feel more challenging 00:22:11 – Days 6–7: Deepening and integrating the practice 00:22:27 – Walking meditation and embodied awareness 00:22:52 – Loving-kindness meditation and compassion training 00:23:02 – Vagal tone, heart rate regulation, and inflammation reduction 00:23:18 – Three rules that determine success 00:23:26 – Eliminating distractions and protecting attention 00:23:36 – Why you should never judge your meditation sessions 00:24:00 – Extending the practice beyond seven days 00:24:19 – Psychedelics, meditation, and the search for transformation 00:24:51 – What the medicine always teaches: sit with yourself 00:25:03 – The wellness industry's tendency to monetize stillness 00:25:20 – Why you don't need expensive tools to transform 00:25:36 – Meditation as radical self-reclamation 00:26:02 – Meeting yourself without distraction 00:26:17 – Final reflections and closing thoughts 00:26:29 – Outro and farewell Thank You to Our Sponsors Alkemis: Go to https://alkemispaint.com/ and use code DARIN10 for 10% off your order. Manna Vitality: Go to mannavitality.com/ and use code DARIN12 for 12% off your order. Join the SuperLife Patreon: This is where Darin now shares the deeper work: - weekly voice notes - ingredient trackers - wellness challenges - extended conversations - community accountability - sovereignty practices Join now for only $7.49/month at https://patreon.com/darinolien Find More from Darin Olien: Website: darinolien.com Instagram: @darinolien Book: Fatal Conveniences Platform & Products: superlife.com New Show: Roadmap to Happiness Key Takeaway "Perhaps one of the most profound discoveries emerging from modern neuroscience is that many of the states of awareness humans have sought through substances, rituals, and external interventions may already be available within us. Meditation is not simply a relaxation practice—it appears to be a biological, neurological, and consciousness-altering intervention capable of reshaping the brain, changing the body, and transforming how we experience reality. The question is not whether the door exists. The question is whether we are willing to sit still long enough to walk through it." Bibliography/Sources: Here is the fully formatted bibliography for the "Seven Days to a New Brain" episode. It is organized by category, formatted in strict APA Style (7th Edition), and includes a direct link for every single source : Primary Studies Brewer, J. A., Worhunsky, P. D., Gray, J. R., Tang, Y. Y., Weber, J., & Kober, H. (2011). Meditation experience is associated with differences in default mode network activity and connectivity. Proceedings of the National Academy of Sciences, 108(50), 20254–20259 . https://doi.org/10.1073/pnas.1112029108 Lieberman, J. M., Rahrig, H., Britton, W. B., et al. (2025). Toward a neuroscience of consciousness using advanced meditation. Neuroscience & Biobehavioral Reviews . https://meditation.mgh.harvard.edu/files/Lieberman_25_NeuroscienceAndBiobehavioralReviews.pdf Pascarella, A., Jerbi, K., et al. (2026). Meditation induces shifts in neural oscillations, brain complexity, and critical dynamics: Novel insights from MEG. Neuroscience of Consciousness . https://pubmed.ncbi.nlm.nih.gov/41287816/ Patel, H., et al. (2025). Intensive meditation retreat induces rapid changes in brain activity, blood-based biomarkers, and neurotrophic signaling. Communications Biology . https://today.ucsd.edu/story/meditation-retreat-rapidly-reprograms-body-and-mind Shinozuka, K., et al. (2025). Neuroelectrophysiological correlates of extended cessation of consciousness in advanced meditation [Preprint]. bioRxiv . https://meditation.mgh.harvard.edu/files/Shinozuka_25_bioRxiv.pdf Van Lutterveld, R., et al. (2025). An intensively sampled electroencephalography case study of advanced concentration absorption meditation (jhana) [Preprint]. SSRN . https://meditation.mgh.harvard.edu/files/VanLutterveld_25_SSRN.pdf Supporting Press Coverage & Explainers Harvard Gazette. (2026, January). Your brain on advanced meditation . https://news.harvard.edu/gazette/story/2026/01/your-brain-on-advanced-meditation/ Medical Xpress. (2026, February). Study of 12 monks finds meditation heightens brain activity, reshaping neural dynamics . https://medicalxpress.com/news/2026-02-monks-meditation-heightens-brain-reshaping.html PsyPost. (2026). Brain scans of Buddhist monks reveal how different meditation styles alter consciousness . https://www.psypost.org/brain-scans-of-buddhist-monks-reveal-how-different-meditation-styles-alter-consciousness/ ScienceDaily. (2026, April 6). Scientists say 7 days of meditation can rewire your brain . https://www.sciencedaily.com/releases/2026/04/260406192913.htm UC San Diego Today. (2026). Meditation retreat rapidly reprograms body and mind. UC San Diego News Center . https://today.ucsd.edu/story/meditation-retreat-rapidly-reprograms-body-and-mind Université de Montréal. (2026, January 5). Meditation doesn't rest the brain, it reshapes it. UdeMNouvelles . https://nouvelles.umontreal.ca/en/article/2026/01/05/meditation-doesn-t-rest-the-brain-it-reshapes-it  

The shift from purely clinical heart failure diagnosis to biomarker-guided management unfolded over decades of incremental evidence, institutional skepticism, and a handful of pivotal decisions by a small number of physician-scientists willing to champion tools before their adoption became mainstream.In this episode of Moving the Needle in Medicine, host Alexander Hajduczok, MD, a cardiologist and heart failure specialist at Oklahoma Heart Institute, interviews Jim Januzzi, MD, the Adolph Hutter Professor of Medicine at Harvard Medical School, chief scientific officer and Gibson chair at the Baim Institute for Clinical Research, and a cardiologist at Massachusetts General Hospital, to explore the formative experiences, clinical innovations, and leadership principles that shaped his career and, more broadly, the evolution of modern cardiology.Januzzi described nearly declining the opportunity to conduct the first US-based clinical studies with NT-proBNP in 2002, having positioned himself primarily as a troponin and acute coronary syndrome researcher. The foundational diagnostic and prognostic work he ultimately led at MGH established the NT-proBNP cutoffs now used internationally, and the test has since evolved from an emergency department dyspnea-evaluation tool into a biomarker applied across all phases of heart failure management. He noted sacubitril/valsartan as a particularly meaningful convergence of therapeutic and biomarker science, consistently producing substantial reductions in NT-proBNP regardless of baseline value, a finding he has incorporated as a practical signal for adequacy of neurohormonal blockade.On the broader arc of guideline-directed medical therapy (GDMT), Januzzi reflected on witnessing the introduction of beta-blockers for heart failure as a fellow, a shift once considered counterintuitive, and tracing the subsequent addition of each pillar as a reminder that even well-established treatment paradigms remain open to displacement by rigorous evidence. He described his involvement in the endpoint committee for the EMPA-REG OUTCOME trial as the entry point for his work with SGLT2 inhibitors in heart failure, another opportunity initially approached with ambivalence. Despite four-pillar GDMT, he noted residual event rates underscore the continued need for novel therapeutics, and he expressed enthusiasm for gene-editing approaches and RNA-silencing therapies now entering cardiovascular development pipelines.Across the conversation, Januzzi returned to the role of mentorship and deliberate career planning, including maintaining clinical trial involvement from early protocol design rather than joining established programs at the phase three stage, advocating for sponsorship alongside mentorship, and structuring academic evolution in intentional five-year increments. The discussion positions biomarker-guided heart failure care not as a completed project but as a framework still being refined as the disease's diagnostic boundaries and therapeutic options continue to expand.

In this episode, Kathryn Butler and Korrie Johnson offer advice and encouragement for parents hoping to engage their kids in reading. Kathryn Butler worked as a trauma surgeon at Massachusetts General Hospital before she left clinical practice to homeschool her children. She now writes regularly about faith, medicine, and the power of great stories. Korrie Johnson is a wife, a mom of three, and the founder of Good Book Mom, a ministry that reviews children's books from a biblical worldview. She has reviewed thousands of books for her website, and she collaborates with 10ofThose to offer families a biblical alternative to Scholastic Book Orders. They are also both co-authors of 'Stories Woven in Silver: Pointing Kids to the Gospel Through Children's Literature' from Crossway. ❖ Listen to “Unicorns, Allegory, and Stories That Give Us Hope" with Kathryn Butler:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Apple Podcasts | Spotify | YouTube If you enjoyed this episode, be sure to leave us a review, which helps us spread the word about the show.

"You shouldn't be spending more than five minutes in there at a time,” says Trisha Pasricha, MD, MPH. A graduate of Harvard College, Pasricha earned her medical degree from Vanderbilt University School of Medicine and a Master of Public Health from the Harvard T.H. Chan School of Public Health. Her training includes an internal medicine residency at The Johns Hopkins Hospital and gastroenterology and motility fellowships at Massachusetts General Hospital. Currently, Pasricha is an assistant professor of medicine at Harvard Medical School and director of the Institute for Gut-Brain Research at Beth Israel Deaconess Medical Center, an NIH-funded research laboratory at the forefront of gut-brain science. Her book, You've Been Pooping All Wrong, is out now.  00:00 - What actually makes a bowel movement healthy 07:55 - The Bristol Stool Chart explained 10:50 - The case for bidets 14:49 - What hemorrhoids actually are 17:44 - The smartphone-hemorrhoid study 20:33 - Fiber timing & psyllium husk 24:03 - The rise in early-onset colorectal cancer 27:43 - Microbiome testing 30:03 - The future of gut health 32:33 - Why we can't poop when traveling 35:40 - How much gas is actually normal 38:01 - Runners with the runs 41:10 - How to overhaul your gut in 30 days Referenced in the episode:  For more about Pasricha, visit her website: https://www.trishapasricha.com/  Buy Pasricha's book here: https://a.co/d/0gZZImBR  Smartphone usage on the toilet study: https://pmc.ncbi.nlm.nih.gov/articles/PMC12407481/ We hope you enjoy this episode, and feel free to watch the full video on YouTube! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Hosts: Jake Lancaster MD, Chief Medical Information Officer and Amanda Comer DNP, System Director, Advanced Practice ProvidersDr. Stephen Threlkeld, Baptist Memorial Health Care's medical director of infectious diseases, contributed to a case study published on Thursday, Jan. 8, 2026, in the prestigious New England Journal of Medicine titled “Case 1-2026: A 50-Year-Old Woman With Fever and Abdominal Pain.”The case study, published in Vol. 394, No. 2 of the journal, is part of a century-old series called “Case Records of the Massachusetts General Hospital.” It explores clinical cases that challenge physicians.CME Credit Info:Link to complete brief survey and claim CME credit: https://www.surveymonkey.com/r/C55LKSYCME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Audible Bleeding editors Falen Demsas, an integrated vascular surgery resident at Massachusetts General Hospital, and Sasank Kalipatnapu (@ksasank), a fifth-year general surgery resident at UMass Chan Medical School, are joined by Megan Tracci (@MeganTracci), James Black (@JamesHBlackMD), and Lauren West-Livingston (LWestLivingston) for a discussion following the inaugural SVS Leadership and Advocacy Summit. In this episode, the group reflects on the importance of surgeon advocacy, highlights key takeaways from the Summit, and discusses how vascular surgeons throughout training and practice can engage in policy, leadership, and organized medicine at local and national levels. The conversation explores the evolving role of advocacy within the Society for Vascular Surgery, including the work of the SVS Advocacy Council and its collaboration across Government Relations, Coding, VA advocacy, and quality and policy initiatives. Dr. Tracci shares insights from her leadership roles within SVS advocacy efforts and her work as ACS Medical Director for Surgeon Engagement. Dr. Black discusses his longstanding advocacy work on behalf of patients and physicians, including numerous trips to Capitol Hill over the course of his career. Dr. West-Livingston reflects on her experience attending the recent Advocacy & Leadership Conference as a trainee and the importance of resident involvement in advocacy work. Show Guests Megan Tracci Leader within the SVS Advocacy Council, which includes Government Relations, Coding, VA advocacy, and quality and policy collaboration efforts. She also serves as the ACS Medical Director for Surgeon Engagement. James Black Chief of Vascular Surgery and Endovascular Therapy at Johns Hopkins University and longtime advocate who has made countless trips to Capitol Hill to advocate for patients and physicians. Lauren West-Livingston Integrated vascular surgery resident at Duke University and member of the SVS Government Relations Committee who attended the recent Advocacy & Leadership Conference. Notable Mentions The inaugural SVS Leadership and Advocacy Summit Advocacy efforts within the Society for Vascular Surgery, including Government Relations, Coding, VA advocacy, and quality and policy collaboration. Learn more here SVS Advocacy Council Opportunities for vascular surgeons to engage in advocacy throughout all stages of training and practice. Sign up for updates Follow us @audiblebleeding Learn more about us at Audible Bleeding and provide us with your feedback through our listener survey. Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

When a company proves it can see what others couldn't, the rules of drug development change overnight. Quantum BioPharma announced on May 18, 2026, that patient enrollment has reached the halfway mark in its collaborative imaging study with Massachusetts General Hospital, accompanied by encouraging preliminary results using a novel PET imaging technique capable of directly assessing demyelinated neurons with intact axons. The company's lead drug candidate, Lucid-MS, targets the underlying mechanism of multiple sclerosis—demyelination—rather than merely suppressing the immune system like most existing therapies. With an IND application submitted to the FDA on April 1, 2026, Quantum BioPharma is positioned at the intersection of breakthrough imaging science and first-in-class therapeutics.WHAT YOU NEED TO KNOWImaging Leap: PET scanning with [18F]3F4AP tracer provides up to 10x more accuracy than conventional MRI in measuring myelin damage and repair—potentially establishing a new FDA biomarker standard.Halfway Validated: First cohort successfully imaged at MGH showing robust signal in acute MS lesions; study completion expected within six months.First-in-Class: Lucid-MS targets PAD2 enzyme to prevent and reverse myelin breakdown—preclinical models demonstrated ability to help animals regain lost mobility.Commercial Scale: MS therapeutic market projected to exceed $38 billion by 2030, affecting 2.8 million patients worldwide with no current therapies addressing mobility restoration.STRATEGIC IMPLICATIONSThe MS treatment landscape is defined by what it cannot do. Virtually every approved therapy focuses on immune modulation—dampening the body's attack on its own myelin. But none address the underlying destruction happening to nerve fibers, and none restore lost mobility. Patients plateau on existing drugs, watching disease progression continue despite treatment. It's a multi-billion-dollar market built on managing symptoms, not reversing damage.Quantum BioPharma's approach disrupts that entire model. By targeting protein arginine deiminase 2 (PAD2)—the enzyme directly implicated in myelin degradation—Lucid-MS addresses neurodegeneration at its source. Phase 1 trials demonstrated a favorable safety profile. Preclinical models showed animals regaining the ability to walk. The oral formulation offers ease of administration versus injection-based competitors. And now, the MGH imaging partnership validates a tool that could measure myelin restoration in real time with unprecedented precision.CEO Zeeshan Saeed:“We've submitted the IND, we're at the halfway mark with MGH, and we're seeing preliminary imaging data that validates what we believed all along. This isn't about managing symptoms. It's about restoring what MS patients have lost. If this works—and we believe it will—we're talking about a fundamentally different standard of care.”INVESTOR TAKEAWAYQuantum BioPharma is executing on multiple fronts simultaneously: advancing a first-in-class therapeutic through FDA review, validating breakthrough imaging science with one of the world's premier hospitals, and preparing for Phase 2 initiation in a $38+ billion market with 2.8 million patients. The MGH study reaching its midpoint with encouraging preliminary results confirms the technical viability of precision myelin measurement. The IND submission positions Lucid-MS for near-term regulatory clarity. And the company's focus on demyelination—rather than immune suppression—addresses the core unmet need in MS: disease reversal, not just disease management. Quantum BioPharma offers investors exposure to a potentially transformative therapy at an inflection point in clinical and commercial validation.

In this episode, we talk with Dr. Nicholas Theodosakis, MD, PhD. Dr. Theodosakis is a physician scientist at Massachusetts General Hospital who completed his MD/PhD at Yale School of Medicine before going on to pursue a combined dermatology residency and research fellowship at the Harvard Combined Dermatology Residency Program. Today, Dr. Theodosakis tells us about his path to dermatology, what it looks like to have a career as a physician scientist and interesting recent findings from his lab that impact our understanding of the skin. Dr. Theodosakis also discusses opportunities for students to work in his research lab. We wrap up with general advice for students interested in research as well as building an application for the field of dermatology. We hope you enjoy!If you enjoyed this episode, please share it with other students interested in dermatology!Learn More:Educational links: Dr. Theodosakis research: https://pubmed.ncbi.nlm.nih.gov/41446198/Email: NTHEODOSAKIS@MGH.HARVARD.EDU---DIGA Instagram: @derminterestToday's Host, George: @georgepapadeas---For questions, comments, or future episode suggestions, please reach out to us via email at derminterestpod@gmail.com ---District Four by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/3662-district-four**License: https://filmmusic.io/standard-license**---

Issued On Behalf of All Companies Mentioned Below. Quantum BioPharma Ltd. QNTM:NASDAQ | QNTM:CSE | 0K91:FSE Quantum BioPharma hit the halfway mark in its PET imaging study with Massachusetts General Hospital, with encouraging early data showing robust signal in acute MS lesions using the [18F]3F4AP tracer. The study validates direct imaging of demyelinated neurons — a key tool for advancing Lucid-MS, the company's lead candidate targeting PAD2 inhibition. Lucid-MS has demonstrated myelin repair in preclinical models, and a Phase 2 IND was submitted to the FDA in March 2026. Draganfly Inc. DPRO:NASDAQ | DPRO:CSE | 3U8:FSE Draganfly launched the Blitz™ payload platform as exclusive North American integrator for Blitz Technology, entering the EO/IR gimbal and drone payload market projected to exceed $12 billion annually by 2030. The Blitz family spans the Spectrum 300 (under 300g, dual EO/IR) to the Spectrum 1600LR (long-range ISR with laser rangefinding), engineered for defense, border security, and public safety. The platform debuts at SOF Week 2026 in Tampa, Florida. Power Metallic Mines Inc. PNPN:TSXV | PNPNF:OTC Markets | IVV1:Frankfurt Stock Exchange Power Metallic entered a 50/50 joint venture framework with Amaar United Mining Company to pursue mining licenses in Saudi Arabia. Amaar Mining will contribute US$7.5 million and Power Metallic US$2.5 million of the initial US$10 million work-program, with equal funding thereafter. Power Metallic acts as technical lead, leveraging its Jabal Baudan license covering 200+ square kilometers in the copper, gold, and zinc-prospective Jabal Sayid Mineralized Belt.Nextech3D.ai NTAR:CSE | NEXCF:OTCQB | 1SS:FSE Nextech3D.ai announced it will serve as lead sponsor and speaker at an EMRG Media event in New York City (October 27-29, 2026), showcasing its Krafty Labs Experience Marketplace alongside its Eventdex registration platform. The integrated AI Event Operating System consolidates engagement, lead capture, and monetization into one unified platform — enabling sponsors measurable ROI through interactive, data-driven experiences. Eventdex will manage full event registration, badge pre-printing, and lead retrieval at the three-day trade show. HPQ Silicon Inc. HPQ:TSXV | HPQFF:OTCQB | O08:FSE HPQ Silicon announced that its French technology partner Novacium SAS signed a Letter of Intent with GH Technologies Co., Ltd. at the 18th China International Battery Fair (May 15, 2026), covering a 36-month framework for GEN4 lithium-ion cells in 18650 and 21700 formats across Asia-Pacific. GEN4 cells feature reported capacity exceeding 6,600 mAh and energy density of 319.9 Wh/kg. HPQ holds a 36.8% equity stake in Novacium and exclusive North American rights under the ENDURA+ trademark. Asia-Pacific accounts for over 57% of global cylindrical Li-ion demand. Stay ahead of the market — follow AGORACOM for more breaking small-cap news and insights.

Welcome to the Oncology Brothers podcast! In this episode, we dived into the complexities of chronic myeloid leukemia (CML) through two challenging case studies. Joined by CML experts Dr. Fadi Haddad from MD Anderson Cancer Center and Dr. Gaby Hobbs from Massachusetts General Hospital,  Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ we talked about: The initial workup for diagnosing CML, including the importance of CBC, bone marrow biopsy, and BCR-ABL testing. How to select the most optimal frontline treatment option amongst many available, considering factors like age, comorbidities, and the goal of treatment-free remission (TFR). The role of first-generation TKI, but also how newer TKIs assist in achieving deeper molecular remissions. Strategies for managing treatment breaks and monitoring patients in remission. The role of ponatinib as a pan-BCR:ABL1 inhibitor effective against all known resistance mutations, including T315I, and the optimized response-based dosing strategy to balance efficacy with safety. Tune in for valuable insights on treatment strategies, patient management, and the latest advancements in CML care. Don't forget to like, subscribe, and share your challenging case scenarios for future discussions! #ChronicMyeloidLeukemia, #CML, #TreatmentFreeRemission, #OncologyBrothers

In this episode of The Visible Voices Podcast, I speak with Dr. Michelle Finkel, emergency medicine physician turned entrepreneur and founder of Insider Medical Admissions — a specialized consulting business helping applicants navigate medical school, residency, fellowship, post-bac, and dental school admissions. Drawing on her experience as faculty at Massachusetts General Hospital and assistant residency director, Michelle shares her high-touch, human-centered approach to helping applicants find their voice, avoid the humility trap, and write with persuasion and originality. We also talk about what it means to embrace a nonlinear career — and why that shift in perspective can reduce stress and open unexpected doors. Find Michelle at insidermedicaladmissions.com ▶ Subscribe on YouTube @resaelewissmd — new Visible Voices episodes on Wednesdays.

In this episode of Bowel Sounds, hosts Dr. Temara Hajjat and Dr. Peter Lu talk to Dr. Maureen Leonard, a pediatric gastroenterologist and Associate Professor at Massachusetts General Hospital. Dr. Leonard discusses the latest research on early life factors that can increase celiac disease risk for susceptible children, including potentially modifiable risk factors. Dr. Leonard's disclosures include:  Consultant for Takeda, Chugai, Anokion, Sonoma, and Interlude Biopharma and research support from Takeda, Pfizer, Regeneron, Moderna, and Mead Johnson Nutrition.Learning objectivesUnderstand early life determinants for celiac diseaseUnderstand environmental influences on developing celiac diseaseSend us Fan MailSupport the showThis episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

President Trump is in China with a delegation drawing scrutiny across Washington: family members, billionaire tech allies and business figures appear front and center, while longtime China experts and senior State Department voices are far less visible. Is Trump on the verge of a corrupt deal for himself and his family that won't serve U.S. or historic interests? Is he prioritizing dealmaking and optics over diplomacy and strategy? Where are experienced American diplomatic voices at this pivotal moment? Mo Kelly is in for Mark Thompson and will discuss this and more. We welcome former federal prosecutor and now defense attorney David Katz to talk about the impending Trump deal with the IRS, redistricting battles headed to court and criticism of the Supreme Court. Then, we pivot to marijuana. Mark welcomes Dr. Peter Grinspoon. He is a primary care physician and a board-certified addiction specialist at Massachusetts General Hospital. Dr. Grinspoon's upcoming book is titled “Aging Well with Cannabis: Feel Better, Sleep Better and Live Better with Marijuana and CBD.” It's a culmination of his hard work to help ‘canna-curious' seniors, family members, and caregivers by providing practical instructions, real-life case studies, and a balanced view of the benefits and risks of cannabis and CBS.

Dr. Peter Grinspoon—author of the new book Aging Well with Cannabis: Feel Better, Sleep Better, and Live Better with Marijuana and CBD—explains that senior citizens are the fastest growing demo of cannabis consumers. But they often need help accessing information and safely ingesting the plant. Dr. Grinspoon is a primary care physician and educator at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, and serves as a board member of the advocacy group Doctors For Cannabis Regulation, which works on legalizing cannabis with an eye toward social justice issues.  PATREON Please ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠support Great Moments in Weed HIstory on Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Supporters get exclusive access to video versions of this podcast and private seshes, plus cool rewards like a signed book. And it truly helps us make the best show possible. EPISODE ARCHIVE Visit our podcast feed for 150+ episodes of Great Moments in Weed History, and subscribe now to get a new weekly podcast every Weednesday.

In this week's podcast episode, Emma shares the story of her son Grady's unexpected NICU journey after experiencing a rare neonatal stroke at birth. What began as a healthy, full-term pregnancy quickly turned into a series of medical emergencies, including respiratory distress, seizures, an emergency transfer to Massachusetts General Hospital, and the discovery of multiple blood clots in Grady's brain.Emma vulnerably reflects on the fear, uncertainty, and trauma of navigating the NICU as a first-time mom while also sharing the hope, resilience, and compassion that carried their family through. As May is Stroke Awareness Month, we are especially honored to share Grady's story and help raise awareness about neonatal stroke and its lasting impact on families.As you listen to Emma's story, we hope that NICU moms navigating unexpected diagnoses or medical trauma feel seen, supported, and reminded that they are never alone!To get connected with DNM:Website | Private Facebook Group | InstagramSupport the show

We can measure more about our health than ever before. Wearables track everything from heart rhythms to glucose trends, and AI can now identify patterns clinicians might miss. But more data does not automatically mean better health outcomes.In this episode, cardiologist and digital health expert Dr. Ami Bhatt joins Mike Haney to explore why medicine still struggles with prevention, how continuous health data can help patients take more agency, and where AI may actually improve care—not by replacing doctors, but by helping clinicians navigate the right information at the right time.They discuss the promise and pitfalls of wearables, the challenge of turning constant streams of health information into useful action, and why the future of medicine may depend on what Dr. Bhatt calls “collaborative intelligence”: humans and AI working together to make better decisions earlier.About the guest: Dr. Ami Bhatt is the chief innovation officer (CIO) at the American College of Cardiology and the Chair of the FDA Digital Health Advisory Committee. She received her undergraduate degree at Harvard University and her Doctor of Medicine at Yale University School of Medicine, and was the Director of Outpatient Cardiology, TeleCardiology, and Adult Congenital Heart Disease at the Massachusetts General Hospital.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠⁠⁠⁠

On this week's episode of the Brain & Life Podcast, co-host Dr. Katy Peters talks with Samantha Lee Schmall, author of Beyond the Shunt, about her personal journey with hydrocephalus. Samantha reflects on growing up with the condition, what inspired her to share her story, and how she's found connection and support within the hydrocephalus community. Dr. Peters is also joined by Dr. Kristopher Kahle, Director of Pediatric Neurosurgery at Massachusetts General Hospital and the Harvard Center for Hydrocephalus and Neurodevelopmental Disorders, who explains what causes hydrocephalus, common symptoms, and current treatment options, including shunts.   Additional Resources Samantha Lee Schmall- Beyond the Shunt Understanding Hydrocephalus: Symptoms, Diagnosis, and Treatment Options Average Joe- Speak Up   Related Episodes of Brain & Life Podcast Author Tanita Allen on Existing with Huntington's Disease A Walk in the "Parkinson's" with Author Annmarie O'Connor Movement and Healing with Adventure Athlete, Author, and Activist Rebecca Rusch   We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at BLpodcast@brainandlife.org   Social Media Guests: Samantha Lee Schmall @beyondtheshunt; Dr. Kahle @mgbneurosurgery Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

We love to hear from our listeners. Send us a message.In episode 128, Host Erin Harris talks to Tatyana Matveeva, Ph.D., Director of cGMP Operations at George  A. "Doc"  Lopez, MD Laboratory for Regenerative Cell Therapy, Harvard Medical School and Massachusetts General Hospital, about leading cGMP operations within an integrated ecosystem, where manufacturing, research, and neurosurgery coexist. Dr. Matveeva highlights key operational challenges in scaling autologous therapies, particularly around technology transfer, process reproducibility, and regulatory readiness, emphasizing the need for early collaboration between research and GMP teams. Their conversation also explores rigorous approaches to chain of identity and custody, the importance of extensive simulation runs to ensure robustness, the unique sensitivities of manufacturing cells for neurological applications, and more.Subscribe to the podcast!Apple  |  Spotify |  YouTubeVisit my website: Cell & GeneConnect with me on LinkedIn

What do tattoos, trafficking survivors, and longevity medicine have in common? More than you'd think. In this episode of Science is Skin, board-certified dermatologist Dr. Ted Lain sits down with Dr. Shadi Kourosh — Harvard Medical School professor, public health physician, and director of dermatology at Nantucket Cottage Hospital — for a conversation that spans medicine, advocacy, and cutting-edge science. Dr. Kourosh shares how her work with underserved communities at Massachusetts General Hospital led her to the frontlines of the fight against human trafficking. She breaks down the "Three I's" — infections, injuries, and imagery — the clinical signs dermatologists and healthcare providers should recognize when a patient may be a trafficking victim. She also discusses trauma-informed care, how to create a safe environment for disclosure, and the STEER app (Skin Signs of Trafficking Education Advocacy and Resources), a free tool designed to connect providers and survivors with local resources. In the second half, Dr. Kourosh pivots to longevity medicine — one of dermatology's fastest-growing frontiers — and explains why separating skin science from snake oil has never been more important for patient protection and consumer health. In this episode: How dermatologists can identify skin signs of human trafficking The Three I's framework: infections, injuries, and imagery in trafficking tattoos Trauma-informed care and the "warm handoff" approach for at-risk patients The STEER app and AAD Human Trafficking Toolkit — free resources for providers Laser tattoo removal as a pathway to safety and reintegration for survivors The new science of skin longevity and preventive dermatology Fact vs. fiction in the longevity medicine space Resources mentioned: STEER App (Skin Signs of Trafficking, Education, Advocacy & Resources) AAD Human Trafficking Toolkit: aad.org American Society for Laser Medicine and Surgery (ASLMS) Polaris Project National Human Trafficking Hotline To watch this and other episodes, be sure to check out our YouTube page DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

Are your kids glued to their screens, and you're not sure how to set limits without starting a battle? Wellness coach Nicole Briggs breaks down her screen time guidelines by age and explains why boredom isn't something to fix, but something to protect.Nicole also reveals the two techniques that resonate most with the kids she coaches — minis and positive self-talk — and how she gets even the most resistant kids to buy in. Finally, Nicole shares her favorite practical tool — the Energy Audit — a simple exercise that can help you identify what drains you and what fills you up, so you can show up as your best self for the kids in your life.Whether you're a parent, teacher, coach or anyone who works with kids and teens, this episode is packed with actionable wisdom you can use today.About NicoleNicole Briggs has been in the wellness industry for over 25 years and has had the privilege of helping more than 10,000 people — from teens to veterans — find relief from stress and reconnect with their health and well-being.Her journey began with a Bachelor's degree in Neuroscience and a deep curiosity about the human mind and body. That curiosity led her to train at Harvard and Massachusetts General Hospital's Mind Body Medicine Program as a Positivity and Resilience Trainer. She is also a certified Life Coach.Today, at Bella Viva Wellness, Nicole helps clients heal from the inside out — teaching them how to relax, unwind the effects of stress, and create real, lasting change. She is passionate about helping her clients learn how to manage stress, because when they do, something powerful happens — they rediscover joy, resilience, and better health.Learn more at: https://www.bellavivacapecod.com/ Thank YouThank you for listening to the Raising Resilient Kids Podcast! We are siblings on a mission to help kids become their strongest selves. Each episode, we share proven strategies with parents, teachers, and all who work with youth and teens to build resilient, confident kids who can tackle life's challenges and thrive.For more information on the podcast, or if you have a question you would like answered by one of our expert guests, please visit us at – https://www.smarthwp.com/raisingresilientkidspodcast.Special Thanks to Our SponsorsMind of a Champion https://smart-hwp.teachable.com/a/aff_9pt0kd23/external?affcode=246901_xpbs0um0The So Happy You're Here YouTube Channel - https://www.youtube.com/@sohappyyouarehereThe Resilient Youth Certification Program - https://www.smarthwp.com/resilient-youth-certification

Season 10, Episode 10: Clearing the Fog: A Clinical Look at Chemo Brain with Jorg Dietrich, MD, PhD Cognitive changes during cancer treatment, often called “chemo brain,” can significantly impact a patient's quality of life. In this episode, Jorg Dietrich, MD, PhD, Clinical Director of the Cancer & Neurotoxicity Clinic at Massachusetts General Hospital and Associate Professor of Neurology at Harvard Medical School, shares his expertise on the neurologic effects of cancer therapies. Dr. Dietrich discusses the biology behind treatment-related cognitive changes, including the impact of chemotherapy, radiation, and immunotherapy on the brain's cellular environment. He provides insight into how these symptoms present in clinical practice and how they can vary across patients. The conversation also focuses on practical strategies for the multidisciplinary oncology team. From early recognition and patient education to supportive care approaches, this episode highlights how pharmacists, providers, and the broader care team can work together to address cognitive side effects and improve patient outcomes. Dr. Dietrich brings a unique perspective through his leadership in cancer neuroscience and brain repair research, with over 200 publications advancing the understanding of neurotoxicity and recovery in cancer care. This episode offers valuable insight for oncology professionals looking to better support patients experiencing cognitive changes throughout their treatment journey.

Non-communicable diseases (NCDs) increasingly represent a leading cause of morbidity and mortality among people with HIV. People with HIV are at high risk of developing NCDs, often at younger ages and more severely than people without HIV. Esteban Martinez from the Hospital Clinic and University of Barcelona, and Steven Grinspoon from the Massachusetts General Hospital and Harvard Medical School, join us to explore the importance of NCDs and how data from the REPRIEVE trial can help us understand and prevent the underlying causes increasing the risk of NCDs in people with HIV. Click here to read the full articles: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00031-7/fulltext https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00354-6/fulltext https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00036-6/fulltext

In today's episode, Haylie Pomroy sits down with Dr. David Systrom, a pulmonary and critical care physician at Mass General Brigham and Assistant Professor at Harvard Medical School, to explore the science behind exercise intolerance in ME/CFS and long COVID. Dr. Systrom breaks down the invasive cardiopulmonary exercise test (CPET) and what it reveals about blood flow, oxygen extraction, and mitochondrial dysfunction in patients who have been told their tests are normal. He explains why dysautonomia, small fiber neuropathy, and acquired mitochondrial dysfunction may be driving the fatigue, post-exertional malaise, and wide-ranging symptoms these patients experience every day. He also shares details on two active clinical trials at Brigham and Women's Hospital, including the LYFT trial testing low-dose naltrexone, Pyridostigmine (Mestinon), and the combination of both, as well as a muscle biopsy study designed to understand the role of the mitochondrion in post-exertional malaise. If you or someone you love has been dismissed, misdiagnosed, or left without answers, tune in to Fast Metabolism Matters Dr. David Systrom is a physician at Brigham and Women's Hospital. He is also an assistant professor of medicine at Harvard Medical School. He received his medical degree from Dartmouth Medical School. He then completed a residency in internal medicine at Emory University Hospital, followed by a fellowship in internal medicine at Massachusetts General Hospital. He is board-certified in internal medicine and pulmonary disease. An active investigator and director of the Massachusetts General Hospital Cardiopulmonary laboratory, Dr. Systrom regularly publishes research examining pulmonary hypertension, pulmonary vascular disease, right heart failure, and thromboembolic disease. He has authored over 130 peer-reviewed publications, has received funding from the National Institutes of Health and the American Heart Association, and has been named to the annual list of the Best Doctors in America. Dr. Systrom is a member of the American Thoracic Society, the American Heart Association and the American Physiological Society. He has special expertise in the pathophysiology of exercise intolerance in ME/CFS and Long Covid and is conducting clinical trials investigating the same   Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet.   Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com   Instagram: https://www.instagram.com/hayliepomroy  Facebook: https://www.facebook.com/hayliepomroy  YouTube: https://www.youtube.com/@hayliepomroy/videos  LinkedIn: https://www.linkedin.com/in/hayliepomroy/  X: https://x.com/hayliepomroy   

Dr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Samuel Klempner from Massachusetts General Hospital in Boston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, and Dr John Strickler from Duke University in Durham, North Carolina, review relevant data supporting immunotherapy for patients with gastroesophageal cancers and review recently presented clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium. CME information and select publications here.

What does recovery look like — and how do we measure it? In this episode, we're joined by Dr. John Kelly, one of the world's leading addiction researchers and founder of the Recovery Research Institute at Harvard Medical School, for a deep dive into the science behind what makes recovery possible, sustainable, and real. Dr. Kelly breaks down the difference between remission and recovery, shares what decades of research tells us about who gets better (spoiler: most people do) and unpacks the active ingredients that help people build lives they love. We also get into the language we use around addiction, why it matters more than you think, and what the latest science says about stigma, stages of change, and recovery capital. Whether you are in recovery, supporting someone who is, or working in the field — this episode is packed with hope, science, and practical insight. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━

In this bonus episode recorded live at the Collegis Education DisruptED summit in Phoenix, we spoke with Marc Austin and Reamer Bushardt to explore how partnerships between higher education institutions and employers can drive more relevant, workforce-aligned learning experiences. Through examples from healthcare and university initiatives, the conversation highlights how co-designed programs, continuous feedback loops, and shared goals can better prepare students for real-world careers.  The discussion emphasizes that successful partnerships require trust, aligned values, and ongoing collaboration—not just transactional agreements. Ultimately, when done well, these partnerships create meaningful pathways for students, improve career outcomes, and strengthen the connection between education and the evolving needs of the workforce. Guest Names:  Dr. Marc Austin, Vice Provost & Managing Director, Montclair Unbound Reamer Bushardt, Provost & VP for Academic Affairs, MGH Institute of Health Professions Guest Socials:Marc's LinkedIn Reamer's LinkedIn Guest Bios: Dr. Marc Austin serves as the Vice Provost and Managing Director for Montclair Unbound, Montclair State University's unit dedicated to extending the reach of the university through online and blended forms of education. Previously, he was the Associate Provost and Dean of Augusta University Online.  Dr. Austin has spent the past two decades launching new, innovative approaches to online, executive and adult learning programs. Dr. Austin has also been a featured speaker for WCET, The Chronicle of Higher Education, ASU/GSV and others. He holds a PhD from Columbia University, a MSc from the London School of Economics and a BA from the University of Pennsylvania. Reamer L. Bushardt, PharmD, PA-C, DFAAPA serves as Professor, Provost and Vice President for Academic Affairs at the MGH Institute of Health Professions, which was founded by the Massachusetts General Hospital and is the only degree granting member of Mass General Brigham. As Provost, he is the Institute's chief academic officer with responsibility for all academic programs, research programs, faculty, and students. Dr. Bushardt is a seasoned educator, researcher, clinician, and administrator with experience in rural, community-based practice and faculty service within four academic health centers. He is licensed as a PA and pharmacist, specializing in the care of older adults and management of inappropriate polypharmacy and drug injury. As a PA, he has spent more than twenty-three years in primary care practice. - - - -Connect With Our Host:Dustin Ramsdellhttps://www.linkedin.com/in/dustinramsdell/About The Enrollify Podcast Network:The Higher Ed Geek is a part of the Enrollify Podcast Network. If you like this podcast, chances are you'll like other Enrollify shows too!Enrollify is made possible by Element451 — The AI Workforce Platform for Higher Ed. Learn more at element451.com. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

BJ Campbell, a Second Amendment advocate, and Dr. Eric Fleegler, a physician and researcher focused on preventing gun violence, were part of a year-long experiment—two dozen people with radically different views on guns meeting month after month to find common ground on policy. It sounds impossible. At first, even they thought it would fail. But something surprising happened: they were able to create a set of gun policies they could all stand behind. How did they do it? ABOUT GUESTS BJ Campbell is a gun owner and Second Amendment advocate who writes for Recoil Magazine and Open Source Defense (https://hwfo.substack.com/p/after-action-report-bridging-the). Dr. Eric Fleegler is a pediatric emergency physician at Massachusetts General Hospital who researches gun violence prevention and firearm-related injury (https://www.massgeneral.org/doctors/23684/eric-fleegler). Learn more about the project and the policies they agreed on - http://bridgethedividenow.org/ CHAPTERS (0:00) Introduction (0:39) A Bold Gun Policy Experiment (1:19) Meet BJ Campbell and Dr. Eric Fleegler (2:06) Expectations and Skepticism (3:48) Dr. Fleegler on Real Compromise (4:42) Background Check Exemptions (6:58) Campbell's Trust Moment on Red Flags (9:08) Humanizing and Building Bonds (12:06) Hope and Limits of Scaling (13:28) Why the Effort Matters (15:02) Conclusion

In episode 75 of Going anti-Viral, Dr Shibani Mukerji joins host Dr Michael Saag to discuss a presentation she gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Cognitive Aging in HIV: Clinical Assessment and Management. Dr Mukerji is an Associate Professor of Neurology at Harvard Medical School and is a practicing neurologist in the Department of Neurology and Division of Infectious Diseases at Massachusetts General Hospital. Her research focuses on HIV pathogenesis in the central nervous system and her clinical focus is neurology-infectious diseases, with specific interests in neurological complications and aging in people living with HIV. Dr Mukerji shares her journey in neurology, her research on HIV and neurological complications, and insights into brain health in aging populations, especially those with HIV. Dr Mukerji and Dr Saag offer practical approaches to cognitive assessment, sleep, mood, and movement issues, emphasizing a longitudinal, patient-centered model of care. 0:00 – Introduction 2:07 – Dr Mukerji 's journey in neurology and infectious diseases7:39 – Cognitive aging in HIV: clinical assessment and management13:26 – Understanding cognitive health in HIV patients18:29 – Assessment and management of depression, sleep, and movement disorders 26:26 – Impact of hearing loss and emotional health on cognitive impairment31:15 – The Valcour tripod: cognitive, motor, and mood assessment34:15 – Future directions in HIV and neurology researchResources: CROI 2026: https://www.croiconference.org/View Dr Mukerji 's presentation at CROI 2026: https://www.croiwebcasts.org/p/2026croi/croi/20 View Presentation by Dr Victor Valcour at CROI 2019: https://www.croiwebcasts.org/p/2019croi/159 __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Guest: This special episode was recorded in front of a live audience at IMMUNOLOGY2026 in Boston. Brenda and Jason sit down with Dr. Charles Sentman, Director of the Center for Synthetic Immunity at Dartmouth College, and Dr. Giulia Escobar, Director of Pre-Clinical Research at Massachusetts General Hospital, to explore new strategies aimed at overcoming the unique challenges of treating solid tumors. They focus on real-world challenges in CAR T and NK cell therapies, including barriers to treating solid tumors, manufacturing and accessibility hurdles, and emerging applications beyond oncology, such as autoimmunity and neurodegenerative disease. Featured Products and Resources: Stay up-to-date with the latest in human immunology news. Download a free wallchart on the production of CAR T cells. Image courtesy of [Drs. Charles Sentman and Giulia Escobar] Subscribe to our newsletter! Never miss updates about new episodes. Subscribe

Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer. CME information and select publications here.

What happens when a Harvard-trained physician rethinks everything he believed about cannabis, stigma, Society's views on cannabis are evolving rapidly. Now legalized in 39 states, marijuana is increasingly making headway in the medical field, particularly amongst senior citizens. I would like to offer my client, Dr. Peter Grinspoon, a board-certified addiction specialist at Massachusetts General Hospital, as well as an Instructor in Medicine at Harvard Medical School, to demystify medical cannabis and provide expert guidance on safe and effective use to alleviate common aging symptoms. As a credentialed primary care physician and cannabis specialist, Dr. Grinspoon addresses the "why" and "how" of cannabis use using science-backed evidence.  With sixty million Americans over sixty-five, many are seeking alternatives to often-harmful pharmaceuticals. Medical marijuana helps with multiple symptoms of aging, such as chronic pain, anxiety, and insomnia, with relatively low toxicity if used properly. In Dr. Grinspoon's upcoming book, Aging Well with Cannabis: Feel Better, Sleep Better and Live Better with Marijuana and CBD,  he helps "canna-curious' seniors, family members, and caregivers by providing practical instructions, real-life case studies, and a balanced view of the benefits and risks of cannabis and CBS.  He guides readers through the buying experience, legal considerations, and becoming a certified medical marijuana patient, emphasizing doctor-patient communication for safe and effective use.Become a supporter of this podcast: https://www.spreaker.com/podcast/arroe-collins-unplugged-totally-uncut--994165/support.

Dr. Ellen Braaten is widely recognized as the foremost expert in pediatric neuro, psychological, and psychological assessment particularly in the areas of assessing learning disabilities and attentional disorders. She is the founding director of Learning and Emotional Assessment Program in Massachusetts General Hospital and an associate professor of psychology at Harvard Medical School. In her new book “The Motivation Mindset Workbook: Helping Teens and Tweens Discover What They Love to Do” she offers practical tools, suggestions, ideas, and activities to help get kids off their phone and unleash their excitement and engagement with life as well as other human beings.

8:05PM: What does space travel do to the human brain and mind? Guest: Dr. Aleksandra Stankovic – investigator in the Center for Space Medicine at Massachusetts General Hospital. Dr. Stankovic is a psychologist (and scuba diver) who is interested in how our brains might be affected by the physical and psychological challenges of long-term space travel. 8:15PM: MA residents win class action lawsuit against the Massachusetts Department of Public Health for auto-installing its “MassNotify” Covid-19 tracking app on more than a million smartphones without the owners’ knowledge or consent. Guest: Peggy Little – New Civil Liberties Alliance Senior Litigation Counsel 8:30PM: Artemis II will face its most dangerous task yet - safely touching down on Earth! A former NASA Test Director will chat with us about what the high risks the crew of the Artemis II must face when returning to Earth!Guest: Mike Ciannilli- former NASA Test Director who spent 30 years inside the U.S. space program in roles that included launch operations leadership, astronaut briefings, and recovery efforts following the Space Shuttle Columbia tragedy. 8:45PM: A look at the new law, championed by the Boston Carmen’s Local 589, makes assault or battery on a public transit worker automatically punishable by imprisonment for at least 90 days or a fine of at least $500.- Boston Carmen’s Union Local 589 praises authorities for arresting man accused of assaulting a female MBTA worker.Guest: Bill Berardino – Vice President of the Boston Carmen’s Local 589 UnionSee omnystudio.com/listener for privacy information.

What if the biggest opportunity in healthcare reimbursement is finally having a clear view of what “fair” actually looks like? In this episode, Dilpreet Sahota, CEO and founder of Trek Health, discusses how his company is helping health systems and health plans turn price transparency data into a strategic tool for payer negotiations. He explains why publicly available reimbursement data is still difficult to use in practice, how AI can simplify both massive pricing datasets and highly complex payer contracts, and why providers need a clearer benchmarking strategy as reimbursement pressures continue to shift. He also shares his perspective on trust, validation, and explainability in AI, along with a future vision in which providers negotiate with greater clarity, and patients can better predict the true cost of care before receiving services. Tune in to learn how better reimbursement intelligence could reduce friction, strengthen negotiation strategy, and increase transparency for both providers and patients. About Dilpreet Sahota: Dilpreet Sahota is the CEO and founder of Trek Health, a company focused on building healthcare payment products that help organizations better understand reimbursement, contracts, and market benchmarks. Since founding Trek Health in 2022, he has worked to make price transparency data more usable for healthcare finance leaders and provider organizations navigating payer negotiations. Before launching Trek Health, Dilpreet held roles across healthcare growth, analytics, operations, and research, including work at Big Health, Health IQ, Massachusetts General Hospital, and Stanford University School of Medicine. He holds an M.Sc. from Stanford University and a B.A. from the University of California, Berkeley. Things You'll Learn: Price transparency data is now public, but it is still difficult for providers and payers to access and use strategically.  AI can help sift through massive pricing datasets and extract key terms from payer contracts in seconds rather than hours.  Providers need plan-specific reimbursement strategies instead of treating all payer relationships the same way. Trust in AI depends on validation, sourcing, auditability, and the ability to trace outputs back to underlying truth. Lower-cost outpatient alternatives will likely play a major role in reducing total cost of care over the next decade. A more mature transparency ecosystem could help patients predict healthcare costs much more accurately before treatment. Resources: Connect with and follow Dilpreet Sahota on LinkedIn. Learn more about Trek Health on LinkedIn and visit the website here. 

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.CME information and select publications here.

Every true crime story has a before. In the Lindsay Clancy case, the before is everything.Lindsay Clancy was a labor and delivery nurse at Massachusetts General Hospital — a woman who worked the room where lives begin and who dedicated her professional life to supporting mothers through their most vulnerable moments. When she became a mother herself, those professional instincts kicked in immediately. She recognized her own symptoms. She sought help almost immediately after each birth. She described exactly what she was experiencing using clinical language, because she had it.She was prescribed medication. It allegedly made things worse. She went back. More medications were added. She went back again. She admitted herself to hospital programs. She kept journals. Her husband was sounding alarms to friends. Her family drove in from out of state to help with the children.And according to a civil malpractice lawsuit she filed in January 2026, through all of it — across more than two years and three pregnancies — no one ever correctly identified the underlying condition that may have been driving everything.Part 2 of our five-part Lindsay Clancy series covers the years before January 24th, 2023. The woman, the mother, the patient, and the pattern of deterioration that her family watched happen while the system allegedly missed it entirely.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#LindsayClancy #TrueCrimeToday #TrueCrime #PostpartumPsychosis #MaternalMentalHealth #TrueCrimePodcast #MentalHealthAwareness #DuxburyMurder #HiddenKillers #WomenTrueCrime

Patrick Clancy came home with dinner on January 24th, 2023. His wife was injured in the backyard. His three children were in the basement. Cora was five. Dawson was three. Callan was eight months old. Within 72 hours, all three were gone.Lindsay Clancy — a devoted mother and labor and delivery nurse at Massachusetts General Hospital — allegedly strangled all three children with exercise bands before attempting to take her own life by jumping from a second-story window. She survived. She is now paralyzed from the chest down, held at Tewksbury State Hospital, awaiting a trial currently scheduled for July 2026.She has pleaded not guilty. Prosecutors allege premeditation — that she calculated Patrick's absence, sent him on a deliberate errand, and created the window intentionally. Her defense maintains she was in active psychosis at the time, hearing a commanding voice she could not resist, the result of a serious illness the medical system allegedly failed to diagnose or treat.In the days after the deaths, Patrick released a public statement of forgiveness that divided the country. The debate it sparked has never stopped.Part 1 of our five-part deep-dive into the Lindsay Clancy case, presented in partnership with Hidden Killers, establishes the foundation: who was lost, who Lindsay was, and what it looks like when two opposing accounts of the same devastating night collide for the first time.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#LindsayClancy #TrueCrimeToday #TrueCrime #PostpartumPsychosis #DuxburyMassachusetts #PatrickClancy #MurderCase #MaternalMentalHealth #TrueCrimePodcast #CriminalJustice

On January 24th, 2023, Patrick Clancy came home to find his wife injured and his three children dead in the basement of their Duxbury, Massachusetts home. Lindsay Clancy — a labor and delivery nurse at Massachusetts General Hospital — is charged with the murders of Cora, five; Dawson, three; and Callan, eight months old. She has pleaded not guilty. Her trial begins July 20th, 2026.The defense says Lindsay spent months before that night desperately seeking help for a postpartum mental health crisis that was being managed with thirteen different medications across multiple providers who weren't coordinating her care. She called a crisis line. She checked into McLean Hospital. She told her husband and her mother she was having thoughts of harming the kids. Her husband called her doctors himself, told them it was urgent. Days later, her dose was raised.Prosecutors say she planned the murders — that phone searches for methods of killing, a calculated timeline for her husband's absence, and the deliberate nature of the attacks point to premeditation, not psychosis. Their expert says the medications in her system could not have caused the break the defense describes.The insanity defense is being prepared. A prosecution psychiatric evaluation is scheduled for April 10th. Her attorney has told the court she remains at daily risk of suicide. Patrick Clancy — who publicly forgave his wife and has said he was married to someone who got sick, not a monster — has had his New Yorker interview subpoenaed by the prosecution.Tony Brueski on True Crime Today lays out both sides of this case with the full context it deserves.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#LindsayClancy #PostpartumPsychosis #DuxburyMurders #TrueCrime #HiddenKillers #PatrickClancy #InsanityDefense #MaternalMentalHealth #TrueCrimePodcast #MurderTrial2026

When Patrick Clancy came home on January 24th, 2023, his wife was in the backyard, seriously injured. She told him she had tried to kill herself. He asked where the children were. She said the basement. What he found down those stairs broke every assumption anyone had about this story.Five days later, Patrick asked the world to forgive Lindsay. As he already had.Lindsay Clancy was a Duxbury, Massachusetts mother of three and a labor and delivery nurse at Massachusetts General Hospital. After the birth of her youngest child, she spent months fighting for her mental health — seeing psychiatrists, visiting ERs, calling crisis lines, checking herself into McLean Hospital. Her husband called her doctors himself and said it was urgent. They were told to keep taking the medications. By January 2023, the defense says she had thirteen different prescriptions from multiple providers in four months with no meaningful coordination between them. The day before everything happened, her doctor raised her dose after a seventeen-minute virtual call.Prosecutors say she planned the murders. That she searched methods of killing. That she calculated her husband's absence and acted with premeditation. That argument goes before a jury on July 20th, 2026.Lindsay has pleaded not guilty. Her defense is lack of criminal responsibility — postpartum psychosis. The prosecution's psychiatric evaluation is set for April 10th. Her attorney has told the court she remains at serious risk of suicide.Patrick has moved to Manhattan. He told The New Yorker he was married to someone who got sick — and prosecutors have subpoenaed the tape.Hidden Killers tells the full story. The one nobody is telling completely.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#LindsayClancy #PostpartumPsychosis #DuxburyMurders #TrueCrime #HiddenKillers #PatrickClancy #InsanityDefense #MaternalMentalHealth #TrueCrimePodcast #MurderTrial2026

Today we're talking about motivation—what it is, what it isn't, and why so many of our neurodivergent kids get mislabeled as “unmotivated” when the real story is far more nuanced. My guest is Dr. Ellen Braaten, an expert on motivation and the author of several books including Bright Kids Who Couldn't Care Less, and her newest release, The Motivation Mindset Workbook: Helping Teens and Tweens Discover What They Love to Do. Ellen shares why motivation is not a fixed trait, how identity shapes whether kids lean in or shut down, and what often gets in the way for learners with ADHD and other differences. We talk about how parents can shift from pushing performance to supporting purpose, and how giving kids the space to discover what genuinely interests them can be transformative for confidence, engagement, and long-term growth. About Dr. Ellen Braaten  Dr. Ellen Braaten is the founding director of the Learning and Emotional Assessment Program (LEAP) at Massachusetts General Hospital and an associate professor at Harvard Medical School. She has published numerous scientific papers on topics related to ADHD, learning disorders, child psychopathology, processing speed, and intelligence, as well as many books for parents and professionals, including the bestsellers Bright Kids Who Can't Keep Up, and Bright Kids Who Couldn't Care Less: How to Rekindle Your Child's Motivation. Most recently, she coauthored The Motivation Mindset Workbook: Helping Teens and Tweens Discover What They Love to Do.Dr. Braaten has a strong interest in educating the public on topics related to child mental health, maintains an active speaking schedule, and contributes regularly to local and national news outlets. Things you'll learn from this episode  How motivation is a dynamic skill that ebbs and flows based on environment and context, not a fixed trait Why helping teens and tweens identify their strengths and values lays the foundation for authentic motivation How responsibility and meaningful real-world experiences spark engagement and ownership Why identity development plays a central role in sustaining long-term motivation How practical, strengths-based activities can reignite momentum when kids feel stuck Resources mentioned  Dr. Ellen Braaten's website The Motivation Mindset Workbook: Helping Teens and Tweens Discover What They Love to Do by Dr. Ellen Braaten & Dr. Hillary Bush Bright Kids Who Couldn't Care Less: How to Rekindle Your Child's Motivation by Dr. Ellen Braaten Bright Kids Who Can't Keep Up: Help Your Child Overcome Slow Processing Speed and Keep Up in a Fast-Paced World by Dr. Ellen Braaten How to Rekindle Your Child's Motivation, with Dr. Ellen Braaten (Tilt Parenting Podcast) Exploring Slow Processing Speed with Dr. Ellen Braaten (Tilt Parenting Podcast) Traits of Flow According to Mihaly Csikszentmihalyi The Clay Center for Young Healthy Minds Dr. Martin Seligman / Positive Psychology Learn more about your ad choices. Visit podcastchoices.com/adchoices

Show notes: (0:00) Intro (1:04) Dr. Naidoo's background and why she joined nutrition psychiatry (4:27) Real patient story on anxiety, travel, and gut imbalance (9:17) Foods that harm gut and mental health (13:47) CALMS foods that support anxiety and mood (16:39) Lifestyle habits that improve mental health (26:16) Her honest view on SSRIs and safe deprescribing (31:08) The S.A.W. method for feeling better every day (35:38) Going extremely low carb (42:04) Where to find Dr. Uma (42:39) Outro   Who is Dr. Uma Naidoo?   Dr. Uma Naidoo is a trained psychiatrist, professional chef, and nutrition specialist who serves as Director of Nutritional & Metabolic Psychiatry at Massachusetts General Hospital and Director of Nutritional & Lifestyle Psychiatry at the Massachusetts General Hospital Psychiatry Academy. She is also an Instructor in the Department of Psychiatry at Harvard Medical School. In her role as a clinical scientist, she founded and directs the first hospital-based clinical service in Nutritional Psychiatry in the United States. Dr. Naidoo is also the author of This Is Your Brain on Food and Calm Your Mind with Food.   Connect with Dr. Uma Website: https://umanaidoomd.com/ LinkedIn: https://www.linkedin.com/in/umanaidoomd/ IG: https://www.instagram.com/drumanaidoo/   Grab a copy: https://umanaidoomd.com/pages/calm-your-mind-with-food Links and Resources: Peak Performance Life Peak Performance on Facebook Peak Performance on Instagram

Identification of pancreatic cystic lesions has become increasingly common due to improved resolution and increased utilization of cross-sectional imaging. However, there are many types of pancreatic cysts, each with varying degrees of malignant potential. In this episode from the HPB team at Behind the Knife, listen in as we discuss the clinical presentation, diagnostic work-up, and management strategies for various pancreatic cysts: Pseudocysts, Serous Cystadenomas, Mucinous Cystic Neoplasms, and IPMNs, amongst others. HostsAnish J. Jain MD (@anishjayjain) is a current PGY4 General Surgery resident at Stanford University and a former T32 Research Fellow at the University of Texas MD Anderson Cancer Center.Jon M. Harrison MD is a Hepatobiliary & Pancreatic (HPB) surgeon at the Massachusetts General Hospital in Boston, MA and a former HPB Surgery fellow at Stanford University. Learning Objectives·      Develop an understanding of the clinical presentation, diagnostic work-up, and treatment of benign pancreatic cysts·      Develop an understanding of the clinical presentation, diagnostic work-up, and treatment of pre-malignant pancreatic cysts·      Develop an understanding of when surveillance is appropriate for management of pancreatic cysts, and the criteria involved in making that determination·      Develop an understanding of the prognostic utility of PancSeq for IPMNsReferences: Paniccia A, Polanco PM, Boone BA, et al. Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts. Gastroenterology. 2023 Jan;164(1):117-133.e7.PubMed Link: https://pubmed.ncbi.nlm.nih.gov/36209796/ Ohtsuka T, Fernandez-Del Castillo C, Furukawa T, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024 Mar;24(2):255-270.PubMed Link: https://pubmed.ncbi.nlm.nih.gov/38182527/ Zelga P, Hernandez-Barco YG, Qadan M, et al. Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm. J Am Coll Surg. 2022 Jun 1;234(6):1021-1030.PubMed Link: https://pubmed.ncbi.nlm.nih.gov/35703792/ Ciprani D, Weniger M, Qadan M, et al. Risk of malignancy in small pancreatic cysts decreases over time. Pancreatology. 2020 Sep;20(6):1213-1217.PubMed Link: https://pubmed.ncbi.nlm.nih.gov/32819844/ ***Fellowship Application Link: https://forms.gle/QSUrR2GWHDZ1MmWC6Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.CME information and select publications here.

Reinvention in the automotive industry is no longer optional. It is survival. In this episode, Jan Griffiths sits down with Lori Lancaster, Vice Chair of Emotiv Mobility, to break down what reinvention really looks like when you are living it, not talking about it from a distance. The old playbook is cracking, and incremental improvement will not get us where we need to go. Yet many leaders are still holding on, waiting for direction instead of stepping up to create it.Lori did not wait. She made the decision to step back from the EV hype, resist the pressure to go all in, and focus instead on the real constraint holding the industry back. Infrastructure. That shift required courage. It meant challenging conventional thinking and refusing to follow the herd. Instead of chasing what everyone else was doing, she looked at where the real opportunity was and made a strategic move to meet it.That decision led to a bold reinvention of the business. By taking core automotive manufacturing capabilities such as process discipline, scale, and precision, Lori and her team expanded into energy and transformer production while exploring emerging mobility spaces like eVTOL. This was not diversification for the sake of it. It was a deliberate move to stabilize the business, reduce reliance on automotive cycles, and position the company for what comes next.But reinvention is not just about strategy. It is about leadership. Lori grounds her approach in servant leadership, accountability, and clarity of purpose. She makes it clear that transformation only works when people understand the why, when they are engaged in the journey, and when leaders create an environment of trust. Without that foundation, even the best strategy will fail.The message is simple and direct. If you are waiting for certainty, you are already behind. If you are waiting for direction, you have missed the point. Reinvention belongs to leaders who are willing to see what is coming, make the hard calls, and move forward without a safety net.Themes Discussed in this EpisodeReinvention as a survival strategyWhy incremental improvement is no longer enoughBreaking free from OEM dependency and legacy thinkingThe real barrier to EV adoption: infrastructure, not vehiclesDiversification beyond automotive to stabilize volatilityTranslating automotive manufacturing discipline into new industriesLeadership courage in high-risk, uncertain decisionsServant leadership vs command-and-control in transformationAccountability through clarity of purpose and shared visionCulture as the foundation for successful reinvention

Electronic Medical Records have transformed the way we practice health care, making patient data readily accessible to health care providers, facilitating collaboration within and across large medical teams, increasing transparency, and drastically improving the legibility of patient charts and prescriptions. But despite these benefits, many physicians cite the electronic medical record as a primary driver of burnout, pointing to the overwhelming volume of documentation it requires. In this episode, we explore how the launch of EMRs within the context of America's predominantly fee-for-service health care system led to the technology falling short of its promise — and how transitioning to value-based care models might redeem the technology, revitalize physicians, and recenter public health. Our guest on this episode is Farzad Mostashari, MD. After completing a degree in public health at Harvard, medical school at Yale, and residency at Massachusetts General Hospital, Dr. Mostashari spent over a decade working in public health: first for the CDC's Epidemic Intelligence Service and then for the New York City Department of Health. From 2009 to 2011, he served as the National Coordinator for Health IT at the Department of Health and Human Services where he helped oversee the nationwide transition from paper to electronic medical records. In 2014, he founded Aledade, a company that helps primary care physicians form value-based care networks in the US.  Over the course of our conversation, Dr. Mostashari shares how his childhood in Iran pushed him towards public health, how his experience watching his father being cared for in the hospital drove him towards medicine, and how he has spent his career in the liminal space between public health and medicine. We discuss the rollout of EMRs, and how fee-for-service payment models led to EMRs being optimized for documentation rather than patient care. We explore how value-based care not only solves the problem of over-documentation, but also better aligns the goals of patients, physicians, and even insurance companies. Dr. Mostashari maps out the progress we have made toward this kind of model and the hurdles we have to clear before we have a system that incentivizes preventing stroke as much as treating stroke. In this episode, you'll hear about: 3:35 - How Dr. Mostashari became drawn to the intersection between the intimate work of doctoring and the wide lens work of public health. 12:12 - Dr. Mostashari's experiences modernizing health IT systems and learning to optimize for the number of lives saved rather than the number of technological solutions implemented.16:05 - Dr. Mostashari's assessment of the rollout of the electronic medical record in the US.25:09 - How Aledade frees primary care physicians to prioritize patient outcomes and reduces the burden of EMR documentation.38:57 - What the US can learn from international health care systems. 41:00 - Challenges in transitioning to outcome-based models of primary care.50:30 - How Dr. Mostashari's medical training has shaped his career in public health. If you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2026

I want to start off by asking a question I continually interest myself with. Do we really want to be happy? If I survey the culture, it looks like we very much want happy moments. The little jolts of dopamine from entertainment, food, drugs and such. But do we really want deep and abiding happiness in our souls? Because if we do, then our primary interest would be in relationships. But not just any relationships. I'm revisiting a conversation I had with Robert Waldinger. Robert is a professor of psychiatry at Harvard Medical School and director of the Harvard Study of Adult Development at Massachusetts General Hospital which has been going on for 87 years. His devotion is on what most equates to human happiness, and the answer is, relationships. But let me point out that Robert himself is a Zen master and teaches meditation around the world. Which is a focus on what I feel is our first and most important relationship. The relationship with ourselves. I have continued to grow in appreciation, not just for the message, but for Robert himself. If you have my book, What Drives You, you'll see his endorsement. Roberts book, which is how I came to know of him, is, The Good Life: Lessons From the World's Longest Scientific Study on Happiness. And you type in, “Robert Waldinger TED” you will find his TED talk, titled, What Makes A Good Life, that between postings on both YouTube and TED has over 80 million views. Sign up for your $1/month trial period at shopify.com/kevin Go to shipstation.com and use code KEVIN to start your free trial. Learn more about your ad choices. Visit megaphone.fm/adchoices